Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone
NACompletedINTERVENTIONAL
Enrollment
10
Participants
Timeline
Start Date
November 30, 2016
Primary Completion Date
January 12, 2018
Study Completion Date
January 12, 2018
Conditions
Major Depressive Disorder
Interventions
DRUG
Ganaxolone
Participants received ganaxolone
Trial Locations (1)
02114
Massachusetts General Hospital, Boston
All Listed Sponsors
lead
Massachusetts General Hospital
OTHER
NCT02900092 - Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone | Biotech Hunter | Biotech Hunter